Prescription drug prices in the United States experienced their most significant drop in over 60 years during July, according to Consumer Price Index data. The Bureau of Labor Statistics reported a 3.1% fall in prices.
While the White House has attributed this decline to President Donald Trump, independent experts cited in a Washington Post article suggest a different cause. They indicate that a policy from the Biden administration, the Inflation Reduction Act, is more likely responsible for driving down costs.
The Inflation Reduction Act, enacted in 2022, mandates Medicare to negotiate prices for certain prescription drugs. Richard Frank, a professor emeritus of health economics at Harvard University, and Stacie Dusetzina, a health policy professor at Vanderbilt University, both expressed that this act is a more probable explanation for the price reduction than any of Trump's initiatives.